Completed PHASE2 INTERVENTIONAL 3-arm NCT03120403

Safety and Efficacy of Intrathecal Morphine in Children

Safety and Efficacy of Intrathecal Morphine in Children Undergoing Major Abdominal Surgeries, Dose-finding Clinical Study

Sponsor: Alaa Ali Mohamed Elzohry

Conditions Abdominal Cancer

Interventions intrathecal morphine

Updated 5 times since 2017 Last updated: Apr 18, 2017 Started: Jul 1, 2016 Primary completion: Mar 30, 2017 Completion: Mar 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Abdominal Cancer, this trial is completed. The trial is conducted by Alaa Ali Mohamed Elzohry and has accumulated 5 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
May 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jul 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alaa Ali Mohamed Elzohry

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.